MXPA04005767A - Formacion previa para hacer tabletas de mezclas naturales de estrogenos conjugados. - Google Patents

Formacion previa para hacer tabletas de mezclas naturales de estrogenos conjugados.

Info

Publication number
MXPA04005767A
MXPA04005767A MXPA04005767A MXPA04005767A MXPA04005767A MX PA04005767 A MXPA04005767 A MX PA04005767A MX PA04005767 A MXPA04005767 A MX PA04005767A MX PA04005767 A MXPA04005767 A MX PA04005767A MX PA04005767 A MXPA04005767 A MX PA04005767A
Authority
MX
Mexico
Prior art keywords
tabletting
formulation
natural mixtures
conjugated estrogens
solid
Prior art date
Application number
MXPA04005767A
Other languages
English (en)
Inventor
Lerch Martina
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of MXPA04005767A publication Critical patent/MXPA04005767A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invencion se relaciona con una formacion previa farmaceutica en forma de un extracto seco solido libremente fluente de mezclas naturales de estrogenos equinos conjugados. Formaciones convenientes de las mezclas naturales mencionadas de estrogeno equinos conjugados se usan para formas galenicas solidas, por ejemplo, para hacer tabletas. Los estrogenos conjugados se proporcionan para el procesamiento galenico posterior en una forma que asegura la estabilidad quimica de las hormonas y permite un procesamiento ventajoso para obtener formas galenicas solidas, por ejemplo tabletas. La invencion se refiere tambien a un metodo para la produccion de esta formacion en forma de un extracto seco.
MXPA04005767A 2001-12-14 2002-12-12 Formacion previa para hacer tabletas de mezclas naturales de estrogenos conjugados. MXPA04005767A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01129840 2001-12-14
PCT/EP2002/014104 WO2003051337A1 (de) 2001-12-14 2002-12-12 Präformulierung für die tablettierung von natürlichen gemischen konjugierter oestrogene

Publications (1)

Publication Number Publication Date
MXPA04005767A true MXPA04005767A (es) 2004-09-10

Family

ID=8179550

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04005767A MXPA04005767A (es) 2001-12-14 2002-12-12 Formacion previa para hacer tabletas de mezclas naturales de estrogenos conjugados.

Country Status (14)

Country Link
US (2) US8273728B2 (es)
EP (1) EP1458363B1 (es)
JP (1) JP4695838B2 (es)
CN (2) CN1298313C (es)
AR (1) AR037642A1 (es)
AU (1) AU2002358682B2 (es)
BR (1) BR0214954A (es)
CA (1) CA2470209A1 (es)
ES (1) ES2403218T3 (es)
HK (2) HK1075007A1 (es)
MX (1) MXPA04005767A (es)
PL (1) PL205544B1 (es)
TW (1) TWI332400B (es)
WO (1) WO2003051337A1 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9586335B2 (en) * 2010-01-27 2017-03-07 Sd3, Llc Blade guard with dust collection
TWI332400B (en) * 2001-12-14 2010-11-01 Solvay Pharm Gmbh Preformulation for the tableting of natural mixtures of conjugated estrogens
US8349819B2 (en) 2002-10-09 2013-01-08 Dr. Reddy's Laboratories New York, Inc. Steroid extraction process from urine sources
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US20090232897A1 (en) * 2008-03-14 2009-09-17 Bijayananda Sahoo Pharmaceutical compositions comprising conjugated estrogens
WO2010144865A2 (en) 2009-06-12 2010-12-16 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
EP2453878A1 (en) * 2009-07-16 2012-05-23 Avantor Performance Materials, Inc. Material and process for incorporation of low dosage active pharmaceutical ingredients and use thereof
CA2856520C (en) 2011-11-23 2021-04-06 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
EP2787987B1 (de) * 2011-12-08 2016-06-01 Hexal AG Neue pharmazeutische statin-zusammensetzung
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
CA3020153A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
WO2021162906A1 (en) * 2020-02-11 2021-08-19 Sheh Fung Screws Co., Ltd Fastener having improved wobble control, fastening system including the same, and method of forming the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3487152A (en) * 1967-02-07 1969-12-30 Hoffmann La Roche Tablets containing 7 - chloro - 2 - methylamino - 5 - phenyl - 3h - 1,4 - benzodiazepine-4-oxide and conjugated estrogenic substances
US4154820A (en) * 1976-02-23 1979-05-15 Akzona Incorporated Compositions containing alkali metal sulfate salts of conjugated estrogens and antioxidants as stabilizers
DE3535536A1 (de) * 1985-10-04 1987-04-09 Lentia Gmbh Verfahren zum gleichzeitigen trocknen und granulieren von extraktstoffen aus enteiweisstem kaelberblut
EP0322020A1 (en) * 1987-12-22 1989-06-28 Akzo N.V. Pharmaceutical dosage unit for treating climacteric complaints and osteoporosis
WO1997004752A1 (en) * 1995-07-26 1997-02-13 Duramed Pharmaceuticals, Inc. Pharmaceutical compositions of conjugated estrogens and methods for their use
PL185919B1 (pl) * 1996-08-30 2003-08-29 Solvay Pharm Gmbh Sposób otrzymywania estrogenów z moczu klaczySposób otrzymywania estrogenów z moczu klaczy
EP0927040B1 (de) 1996-08-30 2004-04-14 Solvay Pharmaceuticals GmbH Prozess zur gewinnung von oestrogenen aus stutenharn
US6200289B1 (en) 1998-04-10 2001-03-13 Milestone Scientific, Inc. Pressure/force computer controlled drug delivery system and the like
JP2000156938A (ja) 1998-11-19 2000-06-06 Hokuto Denko Kk 電池の充放電試験装置
TWI332400B (en) * 2001-12-14 2010-11-01 Solvay Pharm Gmbh Preformulation for the tableting of natural mixtures of conjugated estrogens

Also Published As

Publication number Publication date
JP2005516923A (ja) 2005-06-09
HK1104220A1 (en) 2008-01-11
CN1298313C (zh) 2007-02-07
BR0214954A (pt) 2004-12-14
AU2002358682A1 (en) 2003-06-30
HK1075007A1 (en) 2005-12-02
AU2002358682B2 (en) 2009-03-26
PL205544B1 (pl) 2010-04-30
ES2403218T3 (es) 2013-05-16
US8329679B2 (en) 2012-12-11
US20120237666A1 (en) 2012-09-20
TWI332400B (en) 2010-11-01
CN1607944A (zh) 2005-04-20
CN100502839C (zh) 2009-06-24
CN1977862A (zh) 2007-06-13
PL368730A1 (en) 2005-04-04
US8273728B2 (en) 2012-09-25
US20050009800A1 (en) 2005-01-13
EP1458363B1 (de) 2013-01-16
EP1458363A1 (de) 2004-09-22
WO2003051337A1 (de) 2003-06-26
TW200408400A (en) 2004-06-01
CA2470209A1 (en) 2003-06-26
AR037642A1 (es) 2004-11-17
JP4695838B2 (ja) 2011-06-08

Similar Documents

Publication Publication Date Title
MXPA04005767A (es) Formacion previa para hacer tabletas de mezclas naturales de estrogenos conjugados.
ZA200109859B (en) 6-Alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations.
IL153920A (en) Somatostatin analogues, processes for their production, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for therapy
BR0003158A (pt) Formulação de dosagem oral de derretimentoinstantâneo
AR018143A1 (es) Formulacion para preparar un comprimido de desintegracion rapida, comprimidos de desintegracion rapida, especialmente comprimidos de desintegracionrapida en la boca
HUP0303891A3 (en) Pharmaceutically active piridine derivatives, process for their preparation and pharmaceutical compositions containing them
HK1061203A1 (en) A process for the manufacture of a herbal composition comprising a matrine
IL165977A (en) Substituted pyrimidinylaminobenzamides , process for the preparation thereof and pharmaceutical compositions comprising the same
MXPA04003027A (es) Metodos para granulacion humeda de azitromicina.
SE0103211D0 (sv) New formulations and use thereof
SG114627A1 (en) Water soluble extract from plant of solanum genus and the preparation process thereof, and pharmaceutical composition containing the water soluble extract
ZA200208761B (en) Pharmaceutical form of administration for peptides, methods for its production and use.
HK1069995A1 (en) Water soluble extract from plant of solanum genus and the preparation process thereof, and pharmaceutical composition containing the water soluble extract
WO2003059329A3 (en) Polytartrate composition
IL150528A0 (en) Ibuprofen containing active agent preparation
NO20054417L (no) Fremgangsmate for fremstilling av farmasoytiske preperater i form av fibratholdige tabletter og de derved fremstilte tabletter
EP1291362A4 (en) COMPLEX OF FOLIC ACID AND POLYSACCHARIDES, THE PRODUCTION THEREOF AND THE COMPLEX COMPRISING THE COMPOSITION COMPRISING THE ACTIVE INGREDIENT COMPOSITION
HUP0302515A3 (en) Sulfanidothienopyrimidines, process for their preparation and pharmaceutical compositions containing them
HUP0200625A2 (en) Soya extract containing lipids, process for its production, and pharmaceutical and cosmetic composition
WO2004000265A3 (en) Process for the preparation of robust formulations of valacyclovir hydrochloride tablets
GB2391865B (en) Improvements in the extraction of pharmaceutically active components from plant materials
WO2002024164A3 (fr) Procede de granulation par extrusion basse pression
ES2174734A1 (es) Nueva formulacion galenica de paracetamol dispersable y soluble, procedimiento para su preparacion y aplicaciones.
AU7795800A (en) Method for supercritical fluid extraction
WO2004006831A3 (en) Method and device for inducing biological processes by micro-organs

Legal Events

Date Code Title Description
FG Grant or registration
HC Change of company name or juridical status